CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Galenika Fitofarmacija ad Zemun Company Snapshot
Galenika Fitofarmacija ad Zemun operates in the Agricultural chemicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galenika Fitofarmacija ad Zemun with three other manufacturers of fertilizers and agricultural chemicals in Europe: Amoeba SAS of France (2016 sales of 125,947.00 Euro [US$153,781.29 ] ), Hektas Ticaret T.A.S. of Turkey (176.78 million Turkish Liras [US$43.03 million] ), and Eden Research PLC which is based in the United Kingdom (£391,958.00 [US$546,663.82 ] of which 33% was Licensing fees - is operating).

Sales Analysis. Galenika Fitofarmacija ad Zemun reported sales of 3.94 billion Serbian Dinars (US$40.70 million) for the year ending December of 2016. This represents an increase of 2.9% versus 2015, when the company's sales were 3.82 billion Serbian Dinars. Sales at Galenika Fitofarmacija ad Zemun have increased during each of the previous five years (and since 2011, sales have increased a total of 36%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Galenika Fitofarmacija ad Zemun
  Stock Performance Chart for Galenika Fitofarmacija ad Zemun
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 2,806.00
(Figures in Serbian Dinars)
1 Week -0.1%   13 Weeks -5.8%  
4 Weeks 0.2%   52 Weeks 3.9%  
 
Galenika Fitofarmacija ad Zemun Key Data:
  Ticker: FITO Country: Serbia
  Exchanges: Major Industry: Materials
    Sub Industry: Agricultural Chemicals
  2016 Sales 3,936,257,000
(Year Ending Jan 2017).
Employees: 148
  Currency: Serbian Dinars Market Cap: 7,407,840,000
  Fiscal Yr Ends: December Shares Outstanding: 2,640,000
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.